• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从肝炎到肝细胞癌:炎症和表观遗传机制相互作用的模型。

From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.

机构信息

Epigenetics Group, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France.

出版信息

Genome Med. 2012 Jan 31;4(1):8. doi: 10.1186/gm307.

DOI:10.1186/gm307
PMID:22293089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3334556/
Abstract

Inflammation represents the body's natural response to tissue damage; however, chronic inflammation may activate cell proliferation and induce deregulation of cell death in affected tissues. Chronic inflammation is an important factor in the development of hepatocellular carcinoma (HCC), although the precise underlying mechanism remains unknown. Epigenetic events, which are considered key mechanisms in the regulation of gene activity states, are also commonly deregulated in HCC. Here, we review the evidence that chronic inflammation might deregulate epigenetic processes, thus promoting oncogenic transformation, and we propose a working hypothesis that epigenetic deregulation is an underlying mechanism by which inflammation might promote HCC development. In this scenario, different components of the inflammatory response might directly and indirectly induce changes in epigenetic machineries ('epigenetic switch'), including those involved in setting and propagating normal patterns of DNA methylation, histone modifications and non-coding RNAs in hepatocytes. We discuss the possibility that self-reinforcing cross-talk between inflammation and epigenetic mechanisms might amplify inflammatory signals and maintain a chronic state of inflammation culminating in cancer development. The potential role of inflammation-epigenome interactions in the emergence and maintenance of cancer stem cells is also discussed.

摘要

炎症反应代表了机体对组织损伤的自然应答;然而,慢性炎症可能会激活细胞增殖,并导致受影响组织中的细胞死亡失调。慢性炎症是肝细胞癌 (HCC) 发展的一个重要因素,尽管其确切的潜在机制尚不清楚。表观遗传事件被认为是调节基因活性状态的关键机制,在 HCC 中也经常失调。在这里,我们回顾了慢性炎症可能会使表观遗传过程失调,从而促进致癌转化的证据,并提出了一个工作假设,即表观遗传失调是炎症促进 HCC 发展的潜在机制。在这种情况下,炎症反应的不同成分可能直接或间接地诱导表观遗传机制发生变化(“表观遗传开关”),包括那些参与建立和传播肝细胞中正常的 DNA 甲基化、组蛋白修饰和非编码 RNA 模式的机制。我们讨论了炎症和表观遗传机制之间可能存在的自我强化的交叉对话,这种对话可能会放大炎症信号,并维持导致癌症发生的慢性炎症状态。炎症-表观基因组相互作用在癌症干细胞的出现和维持中的潜在作用也在讨论之中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/3334556/a31ebbe1fd43/gm307-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/3334556/a31ebbe1fd43/gm307-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f6/3334556/a31ebbe1fd43/gm307-1.jpg

相似文献

1
From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.从肝炎到肝细胞癌:炎症和表观遗传机制相互作用的模型。
Genome Med. 2012 Jan 31;4(1):8. doi: 10.1186/gm307.
2
Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.肝细胞癌中的表观遗传机制:环境因素如何影响表观基因组。
Mutat Res. 2011 May-Jun;727(3):55-61. doi: 10.1016/j.mrrev.2011.04.001. Epub 2011 Apr 15.
3
Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌中的表观遗传机制
Hepatoma Res. 2021;7. doi: 10.20517/2394-5079.2020.83. Epub 2021 Feb 3.
4
Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma.整合表观基因组以鉴定肝细胞癌的驱动因子。
Hepatology. 2019 Feb;69(2):639-652. doi: 10.1002/hep.30211. Epub 2019 Jan 5.
5
Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma.影响肝细胞癌发生发展的表观遗传变化
Cancers (Basel). 2021 Aug 23;13(16):4237. doi: 10.3390/cancers13164237.
6
Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.sFRP1的表观遗传沉默激活了经典Wnt信号通路,并促进了肝细胞癌中细胞生长和增殖的增加。
Tumour Biol. 2012 Apr;33(2):325-36. doi: 10.1007/s13277-012-0331-5. Epub 2012 Feb 15.
7
Epigenomics in stress tolerance of plants under the climate change.植物在气候变化下的应激耐受中的表观基因组学。
Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9.
8
Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma.乙型肝炎病毒感染及其相关肝细胞癌的表观遗传修饰。
Virulence. 2024 Dec;15(1):2421231. doi: 10.1080/21505594.2024.2421231. Epub 2024 Nov 20.
9
The loss of hepatitis B virus receptor NTCP/SLC10A1 in human liver cancer cells is due to epigenetic silencing.乙型肝炎病毒受体 NTCP/SLC10A1 在人肝癌细胞中的丢失是由于表观遗传沉默所致。
J Virol. 2024 Oct 22;98(10):e0118724. doi: 10.1128/jvi.01187-24. Epub 2024 Sep 19.
10
Epigenetic remodelling in human hepatocellular carcinoma.人类肝细胞癌中的表观遗传重塑。
J Exp Clin Cancer Res. 2022 Mar 24;41(1):107. doi: 10.1186/s13046-022-02297-2.

引用本文的文献

1
The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway.非酒精性脂肪性肝病中的STING:炎症-致癌途径中的潜在治疗靶点
Pharmaceuticals (Basel). 2022 Oct 9;15(10):1241. doi: 10.3390/ph15101241.
2
Crosstalk Between Inflammatory Signaling and Methylation in Cancer.癌症中炎症信号与甲基化之间的相互作用
Front Cell Dev Biol. 2021 Nov 24;9:756458. doi: 10.3389/fcell.2021.756458. eCollection 2021.
3
Epstein-Barr Virus Promotes B Cell Lymphomas by Manipulating the Host Epigenetic Machinery.

本文引用的文献

1
Epigenetic signatures in stem cells and cancer stem cells.干细胞和癌症干细胞中的表观遗传学特征。
Epigenomics. 2009 Dec;1(2):261-80. doi: 10.2217/epi.09.19.
2
Epigenetic regulation in alcoholic liver disease.酒精性肝病中的表观遗传调控。
World J Gastroenterol. 2011 May 28;17(20):2456-64. doi: 10.3748/wjg.v17.i20.2456.
3
Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.肝细胞癌中的表观遗传机制:环境因素如何影响表观基因组。
爱泼斯坦-巴尔病毒通过操纵宿主表观遗传机制促进B细胞淋巴瘤的发生。
Cancers (Basel). 2020 Oct 19;12(10):3037. doi: 10.3390/cancers12103037.
4
Whole Genome 5'-Methylcytosine Level Quantification in Cirrhotic HCV-Infected Egyptian Patients with and without Hepatocellular Carcinoma.对患有和未患有肝细胞癌的埃及丙型肝炎病毒感染肝硬化患者的全基因组5'-甲基胞嘧啶水平进行定量分析。
Int J Genomics. 2020 Oct 2;2020:1769735. doi: 10.1155/2020/1769735. eCollection 2020.
5
Prognostic value of combined preoperative gamma-glutamyl transpeptidase to platelet ratio and fibrinogen in patients with HBV-related hepatocellular carcinoma after hepatectomy.术前γ-谷氨酰转肽酶与血小板比值联合纤维蛋白原对乙肝相关肝细胞癌患者肝切除术后的预后价值
Am J Transl Res. 2020 Jun 15;12(6):2984-2997. eCollection 2020.
6
Interleukin-6 polymorphisms in HCC patients chronically infected with HCV.慢性丙型肝炎病毒感染的肝癌患者白细胞介素-6基因多态性
Infect Agent Cancer. 2020 Apr 1;15:21. doi: 10.1186/s13027-020-00285-9. eCollection 2020.
7
STAT3 in hepatocellular carcinoma: new perspectives.肝细胞癌中的信号转导与转录激活因子3:新视角
Hepat Oncol. 2014 Jan;1(1):107-120. doi: 10.2217/hep.13.7. Epub 2013 Dec 20.
8
The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis.LINE-1甲基化在预测结直肠癌患者生存率中的作用:一项荟萃分析。
Int J Clin Oncol. 2017 Aug;22(4):749-757. doi: 10.1007/s10147-017-1106-1. Epub 2017 Mar 25.
9
Predicting the impact of non-coding variants on DNA methylation.预测非编码变异对DNA甲基化的影响。
Nucleic Acids Res. 2017 Jun 20;45(11):e99. doi: 10.1093/nar/gkx177.
10
Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.大环内酯类抗生素对人肝癌细胞系HepG2细胞毒性有不同影响,并在大鼠肝癌模型中调节内源性/外源性凋亡途径。
Naunyn Schmiedebergs Arch Pharmacol. 2017 Apr;390(4):379-395. doi: 10.1007/s00210-016-1337-0. Epub 2017 Jan 9.
Mutat Res. 2011 May-Jun;727(3):55-61. doi: 10.1016/j.mrrev.2011.04.001. Epub 2011 Apr 15.
4
Cancer epigenetics: above and beyond.癌症表观遗传学:超越传统认识。
Toxicol Mech Methods. 2011 May;21(4):275-88. doi: 10.3109/15376516.2011.562671.
5
Epigenetic events in tumorigenesis: putting the pieces together.肿瘤发生中的表观遗传事件:整合各方面因素
Exp Oncol. 2010 Sep;32(3):132-6.
6
Cancer epigenetics reaches mainstream oncology.癌症表观遗传学进入主流肿瘤学领域。
Nat Med. 2011 Mar;17(3):330-9. doi: 10.1038/nm.2305.
7
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
8
Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.STAT3 信号通路的激活与肝癌中 twist 和 E-钙黏蛋白的表达相关及其临床意义。
J Surg Res. 2012 May 1;174(1):120-9. doi: 10.1016/j.jss.2010.10.030. Epub 2010 Nov 23.
9
NF-κB and STAT3 - key players in liver inflammation and cancer.NF-κB 和 STAT3 - 肝脏炎症和癌症的关键参与者。
Cell Res. 2011 Jan;21(1):159-68. doi: 10.1038/cr.2010.183. Epub 2010 Dec 28.
10
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.乙型肝炎和丙型肝炎病毒肝癌发生机制:经验教训与未来挑战。
Cancer Lett. 2011 Jun 28;305(2):123-43. doi: 10.1016/j.canlet.2010.11.014. Epub 2010 Dec 18.